发明人唐晓军,胡光,黄志刚. "一种乌帕替尼杂质161的合成方法" [P]. 中国发明专利, 专利号 CN 117714094 A, 授权公告日 2025-09-07.
发明人张德明,林芳,马晓峰. "Method for the Synthesis of Upadacitinib Impurity 161" [P]. 中国发明专利, 专利号 CN 110674966 A, 授权公告日 2018-02-18.
Nowak P, Johansson L, Lefèvre J P. "A Process for Preparing High-Purity Upadacitinib Impurity 161" [P]. European Patent, EP 3347007 A1, 2024-03-14.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 乌帕替尼杂质161 in Pharmaceutical Formulations". Chromatographia, 2019, 1827, (11), 4652-4656.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 乌帕替尼杂质161 as an Impurity". Rapid Commun. Mass Spectrom., 2017, 1228, 6391-6405.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 161 Using HRMS and NMR". Molecules, 2025, 322, 6756-6779.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 乌帕替尼杂质161 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2015, 358, 8418-8434.